CD44 and neoplasm: We have recently shown that blocking CD44-binding to HA with RG7356, an anti-CD44 antibody directed against the constant region of CD44, prevents tumor cell adhesion in vitro and leads to tumor growth inhibition in several in vivo xenograft models [22].